Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024

Rhea-AI Summary

Yield10 Bioscience, Inc. (YTEN) will report Q4 and full year 2023 financial results on April 1, 2024, with a conference call to discuss financials, corporate highlights, and business updates. Interested parties can join the call through various channels and access a replay afterward.

WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024.

Management will host a conference call on Monday, April 1, 2024.at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following management’s formal remarks, there will be a question and answer session.

Interested parties within the U.S. should call 1-877-709-8150 or +1-201-689-8354 (international) to listen to the call. The call will reference a slide deck and be available through a live webcast, both of which can be accessed through the investor relations section of the Company’s website at https://ir.yield10bio.com/ir-events-presentations.

A replay of the call will be available approximately three hours after the end of the call through Monday, April 15, 2024. The replay may be accessed via the Company’s website on the investor relations event page, or by dialing 877-660-6853 (toll-free) or +1-201-612-7415 (international). The audio replay passcode is 13745439.

About Yield10 Bioscience

Yield10 Bioscience, Inc. ("Yield10" or the "Company") is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa ("Camelina") as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and, in the future, PHA biomaterials for use as biodegradable bioplastics. Subject to the availability of sufficient financial resources to continue operations, our commercial plan is based on establishing a grain contracting business leveraging our proprietary elite Camelina seed varieties, focusing on the production of omega-3 oils for nutritional applications and partnering or licensing our advanced Camelina gene technologies to biofuel value chain partners to support their goals of meeting the growing demand for low-carbon intensity feedstock oil. Yield10 is headquartered in Woburn, MA and has a Canadian subsidiary, Yield10 Oilseeds Inc., located in Saskatoon, Canada.

For more information about the Company, please visit www.yield10bio.com, or follow the Company on X (formerly Twitter), Facebook and LinkedIn.

(YTEN-E)

Contact:

Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

FAQ

When will Yield10 Bioscience, Inc. (YTEN) report its Q4 and full year 2023 financial results?

Yield10 Bioscience, Inc. (YTEN) will report its fourth quarter and full year 2023 financial results on Monday, April 1, 2024.

How can interested parties listen to the conference call discussing financial results, corporate highlights, and business updates?

Interested parties within the U.S. should call 1-877-709-8150 or +1-201-689-8354 (international) to listen to the call. The call will reference a slide deck and be available through a live webcast on the investor relations section of the Company’s website.

How long will the replay of the conference call be available?

A replay of the call will be available approximately three hours after the end of the call through Monday, April 15, 2024.